15-min delayed · Sep 11, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Sight Sciences Inc, 4 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $6.00 to $12.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $8.50 sits 5% above the current $8.12. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.13 next quarter toward $-0.43 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy467%
Hold233%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Sight Sciences Inc.
As of Sep, 4 of 6 firms rate SGHT a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SGHT EPS & revenue forecast
EPS · NEXT QUARTER
$-0.13
Range $-0.17 – $-0.08 · 5 analysts · +68% YoY
Next period, 5 analysts expect Sight Sciences Inc to earn $-0.13 a share (range $-0.17 – $-0.08), versus $-0.08 a year earlier. Full-year consensus is $-0.49, growing to $-0.43 the year after.
REVENUE · NEXT QUARTER
$23.7M
Range $23.3M – $24.1M · 5 analysts · +16% YoY
Revenue is expected to reach $23.7M (range $23.3M – $24.1M), +16.3% year-over-year. Full-year consensus is $90.4M, rising to $101.1M next year.
Top analysts covering Sight Sciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SGHT.
#1
David Saxon
Needham · Rank #351
Hold
No targeton SGHT
Overall win rate
32%
+ Follow
#2
Frank Takkinen
Lake Street · Rank #407
Buy
$12.00+47.8% to target
Overall win rate
25%
+ Follow
#3
Matt O'Brien
Piper Sandler · Rank #429
Hold
$3.50-56.9% to target
Overall win rate
25%
+ Follow
#4
Joanne Wuensch
Citigroup
Hold
$6.00-26.1% to target
Coverage
—
+ Follow
#5
TS
Thomas Stephan
Stifel
Buy
$8.00-1.5% to target
Coverage
—
+ Follow
SGHT stock forecast FAQ
What is SGHT's average 12-month price target?+
The 6 analysts with a live target average $8.50 for Sight Sciences Inc over the next 12 months, ranging from a $12.00 high to a $6.00 low.
Is SGHT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 4 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for SGHT?+
The Street-high target is $12.00 (Lake Street), and the Street-low is $6.00 (Citigroup). The average of all 6 active targets is $8.50.
How many Wall Street analysts cover SGHT?+
6 analysts have an active rating on Sight Sciences Inc, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering SGHT?+
Among analysts who currently cover SGHT, David Saxon of Needham has the strongest overall Quantellect track record (Rank #351). Their current call is Hold.
What is Sight Sciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.13 per share (range $-0.17 – $-0.08) across 5 analysts. Full-year EPS is projected at $-0.49, rising to $-0.43 the following year.
How much revenue is Sight Sciences Inc expected to report next quarter?+
Consensus revenue is $23.7M (range $23.3M – $24.1M). Full-year revenue is projected at $90.4M, growing to $101.1M next year.
Have analysts been upgrading or downgrading SGHT lately?+
As of Sep, 4 of 6 firms rate SGHT a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SGHT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
UBS
